Cargando…
Assessing the benefit:risk ratio of a drug - randomized and naturalistic evidence
Randomized evidence from clinical trials and naturalistic evidence collected from pharmacoepidemiology and pharmacovigilance activities both contribute to the initial and continuous assessment of the benefits and risks of a drug, ie, the balance between therapeutic efficacy and safety risks. Benefit...
Autores principales: | Curtin, François, Schulz, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181998/ https://www.ncbi.nlm.nih.gov/pubmed/21842615 |
Ejemplares similares
-
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
por: Tashkin, Donald P., et al.
Publicado: (2019) -
Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
por: Havrdova, Eva, et al.
Publicado: (2017) -
Ethical issues in naturalistic versus controlled trials
por: Helmchen, Hanfried
Publicado: (2011) -
The benefits of contributing to the citizen science platform iNaturalist as an identifier
por: Callaghan, Corey T., et al.
Publicado: (2022) -
The benefits of mind wandering on a naturalistic prospective memory task
por: Girardeau, J. C., et al.
Publicado: (2023)